TP53 mutations emerge in circulating cell-free DNA obtained from patients undergoing treatment with the HDM2 antagonist SAR405838 Meeting Abstract


Authors: Watters, J. W.; Dickson, M. A.; Schwartz, G. K.; Le Cesne, A.; Bahleda, R.; Wagner, A. J.; Choy, E.; De Jonge, M. J.; Light, M.; Jung, J.; Lee, J. S.; Mace, S.
Abstract Title: TP53 mutations emerge in circulating cell-free DNA obtained from patients undergoing treatment with the HDM2 antagonist SAR405838
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036900548
PROVIDER: wos
DOI: 10.1200/JCO.2015.33.15_suppl.2515
Notes: Meeting Abstract: 2515 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark Andrew Dickson
    169 Dickson